BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 10063674)

  • 1. Measles eradication: experience in the Americas.
    de Quadros CA; Hersh BS; Nogueira AC; Carrasco PA; da Silveira CM
    Bull World Health Organ; 1998; 76 Suppl 2(Suppl 2):47-52. PubMed ID: 10063674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress toward measles eradication in the region of the Americas.
    De Quadros CA; Izurieta H; Carrasco P; Brana M; Tambini G
    J Infect Dis; 2003 May; 187 Suppl 1():S102-10. PubMed ID: 12721900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of regional measles surveillance data in the Americas, 1996-99.
    Hersh BS; Tambini G; Nogueira AC; Carrasco P; de Quadros CA
    Lancet; 2000 Jun; 355(9219):1943-8. PubMed ID: 10859039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress toward elimination of measles from the Americas.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1998 Mar; 47(10):189-93. PubMed ID: 9531021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measles eradication in the Americas: progress to date.
    de Quadros CA; Izurieta H; Venczel L; Carrasco P
    J Infect Dis; 2004 May; 189 Suppl 1():S227-35. PubMed ID: 15106116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measles epidemiology and outbreak response immunization in a rural community in Peru.
    Sniadack DH; Moscoso B; Aguilar R; Heath J; Bellini W; Chiu MC
    Bull World Health Organ; 1999; 77(7):545-52. PubMed ID: 10444877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring measles eradication in the region of the Americas: critical activities and tools.
    Izurieta H; Venczel L; Dietz V; Tambini G; Barrezueta O; Carrasco P; Quiroga R; André J; Castillo-Solórzano C; Brana M; Laender F; de Quadros CA
    J Infect Dis; 2003 May; 187 Suppl 1():S133-9. PubMed ID: 12721904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Achieving measles control: lessons from the 2002-06 measles control strategy for Uganda.
    Mbabazi WB; Nanyunja M; Makumbi I; Braka F; Baliraine FN; Kisakye A; Bwogi J; Mugyenyi P; Kabwongera E; Lewis RF
    Health Policy Plan; 2009 Jul; 24(4):261-9. PubMed ID: 19282484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress toward elimination of rubella and congenital rubella syndrome--the Americas, 2003-2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Oct; 57(43):1176-9. PubMed ID: 18971920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measles resurgence following a nationwide measles vaccination campaign in Nigeria, 2005-2008.
    Weldegebriel GG; Gasasira A; Harvey P; Masresha B; Goodson JL; Pate MA; Abanida E; Chevez A
    J Infect Dis; 2011 Jul; 204 Suppl 1():S226-31. PubMed ID: 21666165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measles eradication: recommendations from a meeting cosponsored by the World Health Organization, the Pan American Health Organization, and CDC.
    MMWR Recomm Rep; 1997 Jun; 46(RR-11):1-20. PubMed ID: 9213745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of nationwide measles vaccination campaign among children aged 9 months to 14 years, Zimbabwe, 1998-2001.
    Munyoro MN; Kufa E; Biellik R; Pazvakavambwa IE; Cairns KL
    J Infect Dis; 2003 May; 187 Suppl 1():S91-6. PubMed ID: 12721898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress toward measles elimination--European Region, 2005--2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Feb; 58(6):142-5. PubMed ID: 19229166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress in measles and rubella elimination in Iran.
    Esteghamati A; Gouya MM; Zahraei SM; Dadras MN; Rashidi A; Mahoney F
    Pediatr Infect Dis J; 2007 Dec; 26(12):1137-41. PubMed ID: 18043452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measles epidemiology and elimination strategies in Turkey.
    Güriş D; Bayazit Y; Ozdemirer U; Buyurgan V; Yalniz C; Toprak I; Aycan S
    J Infect Dis; 2003 May; 187 Suppl 1():S230-4. PubMed ID: 12721918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained high coverage of insecticide-treated bednets through combined Catch-up and Keep-up strategies.
    Grabowsky M; Nobiya T; Selanikio J
    Trop Med Int Health; 2007 Jul; 12(7):815-22. PubMed ID: 17596247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress toward measles elimination--region of the Americas, 2002-2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Apr; 53(14):304-6. PubMed ID: 15085074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility of global measles eradication after interruption of transmission in the Americas.
    de Quadros CA; Andrus JK; Danovaro-Holliday MC; Castillo-Solórzano C
    Expert Rev Vaccines; 2008 Apr; 7(3):355-62. PubMed ID: 18393605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distributing insecticide-treated bednets during measles vaccination: a low-cost means of achieving high and equitable coverage.
    Grabowsky M; Nobiya T; Ahun M; Donna R; Lengor M; Zimmerman D; Ladd H; Hoekstra E; Bello A; Baffoe-Wilmot A; Amofah G
    Bull World Health Organ; 2005 Mar; 83(3):195-201. PubMed ID: 15798843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress toward measles elimination--Southern Africa, 1996-1998.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1999 Jul; 48(27):585-9. PubMed ID: 10428097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.